Methodology
The rules behind every price, program, profile, review, comparison, and correction published by Telehealth Ledger.
Scope and unit of comparison
A comparison unit is one medication in one delivery format. Injection, oral, nasal, compounded, brand-name, and service-only products are not silently merged. Coverage is limited to programs with public evidence that the site has reviewed; it is not a census of every US telehealth company.
Source collection
Price and program facts come from public provider pages, provider help centers, terms, pricing pages, and program landing pages. Each published price resolves to a source and a verification date. When a provider does not publish a price before intake, the record says “not published”; no number is estimated to fill the gap.
Price normalization
Introductory price, continuing monthly price, upfront charge, prepaid-effective monthly price, and commitment length are stored separately. Medication inclusion is also separate. This prevents a discounted first month or a large prepayment from masquerading as a cheaper continuing month-to-month program.
Ranked comparisons
Tables sort on continuing price when available, then prepaid-effective monthly price, then a one-time upfront price. Programs with no public price appear last. A treatment comparison is indexable only when at least three distinct providers publish compatible prices for that exact treatment and format.
“Lowest” therefore means lowest comparable published figure among providers tracked on that page at the displayed verification dates—not cheapest everywhere.
Provider and route publication gates
A provider profile needs a secure public destination, source-backed program facts, and no unresolved publication hold. New provider records receive additional checks for official identity, medical or administrative roles, operating terms, evidence consistency, and outbound destination safety.
Coupons, reviews, provider-versus-provider comparisons, and branded treatment guides each have independent evidence gates. They are explicit editorial records, never an automatically generated cross-product of names.
Reviews and editorial evidence
Reviews require original analysis, multiple public sources, and—under the current provider gate—at least two independent source classes. Safety articles distinguish a regulator notice, a company announcement, and clinical literature rather than treating them as interchangeable evidence.
Search-volume estimates may prioritize research but never prove clinical value, provider quality, or user demand. Modeled volume is labeled as modeled and stays separate from first-party traffic or conversion data.
Updates and corrections
Provider terms can change without notice. Material corrections are rechecked against public sources and receive a new verification date. A route can leave the sitemap or become unavailable when its evidence no longer satisfies the publication gate.
Limitations and commercial disclosure
Telehealth Ledger does not assess medical suitability or prescribe care. State access, eligibility, pharmacy, inventory, dose, and checkout totals can change after a clinical intake. Readers must verify current terms directly with the provider.
Some outbound links generate affiliate commission. Commercial relationships do not control table order, recorded facts, route eligibility, or editorial conclusions. Read the complete disclosures and the AI source guidance.